Clinical trial · Interventional
Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment
NCT03612804CI-TRIAL-00081399PROACTcompletedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This pragmatic trial will evaluate the value of routinely providing proactive smoking cessation support to current smokers as a part of participating in lung cancer screening within Veterans Health Administration.
Conditions
Conditions (6)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Diseases | — | UNRESOLVED | — |
| Lung Neoplasms | Lung Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Smoking Reduction | — | UNRESOLVED | — |
| Tobacco Smoking | — | UNRESOLVED | — |
| Tobacco Use | — | UNRESOLVED | — |
| Tomography | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Proactive Telephone Counseling from VA Quitline | Behavioral | — | UNRESOLVED |
| Unsigned note to provider about cessation medication prescription | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Unstructured care
- description
- Providers in this arm will continue to provide care as usual during lung cancer screening, with no intervention from the study team.
- type
- EXPERIMENTAL
- label
- Proactive care
- description
- Providers in this arm will receive guidance from the study team about offering lung cancer screening patients proactive cessation care, including cessation medications and behavioral telephone counseling.
- interventionNames
- Behavioral: Unsigned note to provider about cessation medication prescription
- Behavioral: Proactive Telephone Counseling from VA Quitline
Primary outcomes (1)
- measure
- Self-reported Smoking Abstinence
- timeFrame
- 12 months after lung cancer screening visit
Eligibility
Eligibility (as posted)
- Sex
- All
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Providers who schedule patients for a lung cancer screening at either of the two VA sites. * Patients who participate in lung cancer screening and are current smokers at the time of scheduling their screening exam. Exclusion Criteria: * Providers who currently systematically prescribe cessation support medication to all current smokers will be excluded. * Patients with urgent findings requiring biopsy/immediate attention on the screening CT will be excluded. * Patients with a prior diagnosis of lung cancer or who are receiving active therapy for any cancer, except skin cancer, will be excluded. * Patients previously diagnosed with cognitive impairment, dementia, or severe behavioral disorders, or have an indication in chart review of difficulty communicating or participating in telephone counseling sessions will be excluded.
References
Publications (0)
Data not yet available
No reference posted for this study.